Related Experiment Videos

Impact of randomized controlled trials on the progress of therapy in cardiovascular diseases

J P Boissel

    Revue D'Epidemiologie Et De Sante Publique
    |January 1, 1984
    PubMed

    Insights

    Randomized controlled trials (RCTs) may not significantly advance cardiovascular therapies. Poor understanding of RCT methodology and inadequate doctor information systems are potential reasons for this limited impact.

    Area of Science:

    • Clinical Research Methodology
    • Cardiovascular Medicine
    • Health Services Research

    Background:

    • The link between randomized controlled trials (RCTs) and therapeutic progress is crucial for stakeholders in healthcare.
    • Currently, assessing this relationship relies on indirect methods, with limited research specifically addressing it.

    Purpose of the Study:

    • To investigate the role and impact of randomized controlled trials (RCTs) on the development of cardiovascular disease therapies.
    • To identify potential barriers hindering the effective translation of RCT findings into clinical practice.

    Main Methods:

    • Review of existing literature and evidence on the application and outcomes of RCTs in cardiovascular medicine.
    • Analysis of factors influencing the utilization and understanding of RCT methodology.

    Main Results:

    • Available evidence suggests RCTs have had a limited role in advancing cardiovascular therapies.
    • Key factors identified include a lack of understanding and poor application of RCT methodology.
    • Inadequacies within healthcare professionals' information systems also contribute to this issue.

    Conclusions:

    • RCTs may not be effectively driving progress in cardiovascular therapy as anticipated.
    • Improving the understanding and application of RCT methodology is essential.
    • Enhancing medical information systems is critical for better integration of research findings into patient care.

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    265
    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    10.1K
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    4.4K
    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

    Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
    Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
    335
    Blinding01:11

    Blinding

    Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
    3.8K
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    816